Association between urinary symptoms and quality of life in HTLV-1 infected subjects without myelopathy
AUTOR(ES)
Andrade, Rosana, Tanajura, Davi, Santana, Deise, Santos, Dislene dos, Carvalho, Edgar M.
FONTE
Int. braz j urol.
DATA DE PUBLICAÇÃO
2013-12
RESUMO
Objective To investigate the relationship between urinary symptoms and quality of life of patients infected with HTLV-1. Materials and Methods This is a cross-sectional study that enrolled individuals with HTLV-1 positive serology from February 2010 to March 2011. Participants were HTLV-1 infected subjects followed in the HTLV-1 clinic of the University Hospital in Salvador, Bahia, Brazil. Patients with HTLV-1 associated myelopathy / tropical spastic paraparesis (HAM/TSP), who had evidence of other neurological diseases, diabetes mellitus or were pregnant were excluded from the study. The questionnaire SF-36 was used to evaluate quality of life and the questionnaire OAB-V8 was used to evaluate urinary symptoms. Results From the 118 individuals evaluated, 50 (42.4%) complained of urinary symptoms and 68 (57.6%) did not. Most participants were females. There was no difference between the groups regarding demographic variables. The group with symptoms showed significantly lower scores in all domains of the SF-36 questionnaire. The domains with greatest differences were vitality and general health state. Conclusions Urinary symptoms negatively influence the quality of life of individuals infected with HTLV-1.
Documentos Relacionados
- Functional capacity assessment and quality of life in patients with myelopathy assosciated to the HTLV-1
- Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients
- Quality of life and pain multidimensional aspects in individuals with HTLV-1
- Neurologic abnormalities in HTLV-I– and HTLV-II–infected individuals without overt myelopathy
- High HTLV-1 proviral load, a marker for HTLV-1 associated myelopathy/tropical spastic paraparesis, is also detected in patients with infective dermatitis associated with HTLV-1